Journal articleClin Cancer Res2022
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response.
- Journal
- Clin Cancer Res
- Published
- 1 August 2022
- Citations
- 79
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 4
- Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine K08CA248710↗
- Administrative Core P01CA247886↗
- Core 2: Biospecimen/Pathology Core P50CA062924↗
- Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial R01CA197296↗